Yahoo Web Search

    • Immunic, Inc. to Participate in Investor Conferences in December

      Salamanca Press· 4 days ago

      NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune